about
Systematic identification of signaling pathways with potential to confer anticancer drug resistance.ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer.Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid Leukemia.Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance.PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution.Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivityGenomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models
P50
Q35159023-B84B0C76-946A-48C8-BCA7-8512A4470FA7Q36803802-A5E35658-6854-4738-B86B-970E38D08E06Q36990787-1122193E-D59A-4042-967A-ED18A27D70E5Q42200131-A38CB19E-7095-4818-8AD9-AB9B7ACF412BQ42283077-A945A09D-BDD8-4E81-8341-1A9B2FFCDC4CQ48711405-C24724FE-DA6C-498F-9AF8-CBCF34857F91Q58695490-6CBC03F5-54A0-4E02-9301-8B882FEC69F2Q90089266-D3A7F4D7-E2BB-4E0E-A3FD-C71EC2DCA595
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2493-2510
@en
name
Grace R Anderson
@ast
Grace R Anderson
@en
Grace R Anderson
@es
Grace R Anderson
@nl
type
label
Grace R Anderson
@ast
Grace R Anderson
@en
Grace R Anderson
@es
Grace R Anderson
@nl
prefLabel
Grace R Anderson
@ast
Grace R Anderson
@en
Grace R Anderson
@es
Grace R Anderson
@nl
P106
P1153
56463346600
P31
P496
0000-0002-2493-2510